lobbying_activities: 2341229

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2341229	49c46be6-48a5-47d7-beaf-3e7ade1c352c	Q3	POLSINELLI PC	314911	TEVA PHARMACEUTICALS USA, INC.	2019	third_quarter	PHA	S.2543, Prescription Drug Pricing Reduction Act S.1895, Lower Health Care Costs Act H.R. 3, Lower Drug Costs Now Act H.R.2375/ S.64, Preserve Access to Affordable Generics and Biosimilars Act H.R.2296, METRIC Act Administration review of drug pricing policies	HOUSE OF REPRESENTATIVES,SENATE	80000		0	0	2019-10-14T11:24:44.610000-04:00